利妥昔单抗联合α干扰素治疗复发难治性弥漫性大B细胞非霍奇金淋巴瘤 - Suppr

Rituximab in combination with interferon-alpha in relapsed and refractory diffuse large B-cell non-Hodgkin's lymphoma.

作者信息

Bertè R, Vallisa D, Civardi G, Moroni C F, Lazzaro A, Cavanna L

机构信息

Department of Internal Medicine, Hematology and Oncology Program, Hospital of Piacenza, Italy.

出版信息

Acta Haematol. 2001;106(3):141-2. doi: 10.1159/000046607.

DOI:10.1159/000046607

PMID:11713384

Abstract

摘要

相似文献

Rituximab in combination with interferon-alpha in relapsed and refractory diffuse large B-cell non-Hodgkin's lymphoma.

Acta Haematol. 2001;106(3):141-2. doi: 10.1159/000046607.

Rituximab in heavily pretreated cutaneous B-cell lymphoma.

Leuk Lymphoma. 2003 Sep;44(9):1637-8. doi: 10.3109/10428190309178793.

Rituximab combined with MACOP-B or VACOP-B and radiation therapy in primary mediastinal large B-cell lymphoma: a retrospective study.

Clin Lymphoma Myeloma. 2009 Oct;9(5):381-5. doi: 10.3816/CLM.2009.n.074.

[Treatment strategy of gray zone lymphomas].

Rinsho Ketsueki. 2014 Oct;55(10):1912-9.

Effect of combination chemotherapy with cefoperazone on non-Hodgkin's lymphoma.

Leuk Res. 1992;16(4):417-8. doi: 10.1016/0145-2126(92)90146-x.

Clin Adv Hematol Oncol. 2005 Mar;3(3):231-4; discussion 234-5.

Rapid regression of chemotherapy refractory lymphocyte predominant Hodgkin's disease after administration of rituximab (anti CD 20 mono- clonal antibody) and interleukin-2.

Leuk Lymphoma. 1999 Nov;35(5-6):641-2. doi: 10.1080/10428199909169633.

Dacetuzumab plus rituximab, ifosfamide, carboplatin and etoposide as salvage therapy for patients with diffuse large B-cell lymphoma relapsing after rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone: a randomized, double-blind, placebo-controlled phase 2b trial.

Leuk Lymphoma. 2015;56(9):2569-78. doi: 10.3109/10428194.2015.1007504. Epub 2015 Feb 26.

[Treatment strategy of Hodgkin lymphoma].

Rinsho Ketsueki. 2014 Oct;55(10):1941-51.

Clinical outcomes of AIDS-related Burkitt lymphoma: a multi-institution retrospective survey in Japan.

Jpn J Clin Oncol. 2014 Apr;44(4):318-23. doi: 10.1093/jjco/hyu012. Epub 2014 Feb 20.

引用本文的文献

Toll-like Receptor 4 Ligands Down-regulate Fcγ Receptor IIb (FcγRIIb) via MARCH3 Protein-mediated Ubiquitination.

J Biol Chem. 2016 Feb 19;291(8):3895-904. doi: 10.1074/jbc.M115.701151. Epub 2015 Dec 22.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Rituximab in combination with interferon-alpha in relapsed and refractory diffuse large B-cell non-Hodgkin's lymphoma.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

Rituximab in combination with interferon-alpha in relapsed and refractory diffuse large B-cell non-Hodgkin's lymphoma.

作者信息

机构信息

出版信息

相似文献

引用本文的文献